Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Apr 2026 for INOVIO PHARMACEUTICALS, INC..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Michael John Sumner: trading record in brief
Michael John Sumner appears in our data through filings on Inovio Pharmaceuticals, Inc. shares, published by SEC (Form 4). In total, 12 filings cover trades dated from 30 June 2023 to 31 March 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 1 April 2026: a share grant of €1,839, in Inovio Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael John Sumner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
4,292 sharesCommon StockSEC:0001936799-26-000004:0
1,223 shares@ US$1.74100.0% of flowCommon StockSEC:0001936799-26-000004:1
5,010 sharesCommon StockSEC:0001936799-26-000002:0
2,916 sharesCommon StockSEC:0001055726-25-000046:0
2,385 sharesCommon StockSEC:0001055726-25-000031:0
680 shares@ US$1.95Common StockSEC:0001055726-25-000031:1
5,010 sharesCommon StockSEC:0001055726-25-000004:0
2,917 sharesCommon StockSEC:0001055726-24-000042:0
2,386 sharesCommon StockSEC:0001055726-24-000029:0
35,000 sharesCommon StockSEC:0001055726-23-000045:0
10 of 10 declarations
